assembly Bill A2904

2019-2020 Legislative Session

Prohibits certain insurance policies from requiring prior authorization for certain medications used in the treatment of substance use disorders; repealer

download bill text pdf

Sponsored By

Current Bill Status - Passed Senate & Assembly


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (11)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 03, 2019 returned to assembly
passed senate
3rd reading cal.1142
substituted for s4808
Apr 10, 2019 referred to insurance
delivered to senate
passed assembly
Mar 21, 2019 advanced to third reading cal.152
Mar 18, 2019 reported
Mar 12, 2019 reported referred to codes
Jan 28, 2019 referred to insurance

Co-Sponsors

Multi-Sponsors

A2904 (ACTIVE) - Details

See Senate Version of this Bill:
S4808
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, rpld §3216 sub§ (i) ¶31-a, §3221 sub§ (l) ¶¶7-a & 7-b, §4303 sub§§ (l-1) & (l-2), Ins L
Versions Introduced in 2017-2018 Legislative Session:
A7979, S6674

A2904 (ACTIVE) - Summary

Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.

A2904 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  2904

                       2019-2020 Regular Sessions

                          I N  A S S E M B L Y

                            January 28, 2019
                               ___________

Introduced  by M. of A. QUART -- read once and referred to the Committee
  on Insurance

AN ACT to amend the insurance law, in relation  to  prohibiting  certain
  insurance  policies  from  requiring  prior  authorization for certain
  medications used in the treatment of substance use disorders;  and  to
  repeal certain provisions of such law relating thereto

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Paragraph 31-a of subsection (i) of  section  3216  of  the
insurance  law  is REPEALED and a new paragraph 31-a is added to read as
follows:
  (31-A) (A) NO POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL  OR  SIMILAR
COMPREHENSIVE-TYPE COVERAGE AND PROVIDES COVERAGE FOR PRESCRIPTION DRUGS
FOR  MEDICATION  FOR  THE  TREATMENT  OF  A SUBSTANCE USE DISORDER SHALL
REQUIRE PRIOR AUTHORIZATION FOR AN INITIAL OR RENEWAL  PRESCRIPTION  FOR
ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREX-
ONE  FOR  DETOXIFICATION  OR  MAINTENANCE  TREATMENT  OF A SUBSTANCE USE
DISORDER EXCEPT WHERE OTHERWISE PROHIBITED BY LAW.
  (B) COVERAGE PROVIDED UNDER THIS PARAGRAPH MAY BE  SUBJECT  TO  COPAY-
MENTS,  COINSURANCE,  AND  ANNUAL  DEDUCTIBLES  THAT ARE CONSISTENT WITH
THOSE IMPOSED ON OTHER BENEFITS WITHIN THE POLICY.
  § 2. Paragraphs 7-a and 7-b of subsection (l) of section 3221  of  the
insurance  law  are REPEALED and a new paragraph 7-a is added to read as
follows:
  (7-A) (A) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR
COMPREHENSIVE-TYPE LARGE GROUP COVERAGE SHALL PROVIDE IMMEDIATE COVERAGE
FOR ALL BUPRENORPHINE PRODUCTS,  METHADONE  OR  LONG  ACTING  INJECTABLE
NALTREXONE WITHOUT PRIOR AUTHORIZATION FOR THE DETOXIFICATION OR MAINTE-
NANCE TREATMENT OF A SUBSTANCE USE DISORDER.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD01428-01-9

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.